Cyclosporin A inhibits angiotensin II-induced c-Jun NH2-terminal kinase activation but not protein synthesis in vascular smooth muscle cells

European Journal of Pharmacology

Volumn 443, Issue 1-3, 2002, Pages 47-50

  Saito, Shuichi ^a   Frank, Gerald D ^a   Motley, Evangeline D ^b   Utsunomiya, Hirotoshi ^c   Inagami, Tadashi ^a   Eguchi, Satoru ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEHARRY MEDICAL COLLEGE   (United States)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin II; c Jun NH2 terminal kinase; Cyclosporin A; Smooth muscle cell, vascular

Indexed keywords

ANGIOTENSIN; CALCINEURIN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TACROLIMUS;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0037123871     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01587-X     Document Type: Article

References (23)

1. Angiotensin II signal transduction in vascular smooth muscle: Pathways activated by specific tyrosine kinases
2. Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis
3. Calcium, calcineurin, and the control of transcription
4. 2-terminal kinase activation in the heart
5. Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells
6. Calcium-dependent epidermal growth factor receptor trasnactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells
7. Epidermal growth factor receptor is indispensable for c-Fos expression and protein synthesis by angiotensin II
8. Activation of MAPKs by angiotensin II in vascular smooth muscle cells
9. Unique regulation of c-Jun N-terminal kinase by PYK2/CAK-β in angiotensin II-stimulated vascular smooth muscle cells
10. Angiotensin II signaling in vascular smooth muscle. New concepts
11. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases
12. 2-terminal kinase in cultured cardiac myocytes of neonatal rats
13. Cyclospolin A inhibits nitric oxide synthase induction in vascular smooth muscle cells
14. T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A
15. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
16. 2-terminal kinase
17. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
18. Angiotensin II stimulates p21-activated kinase in vascular smooth muscle cells. Role in activation of JNK
19. 2-terminal kinase is mediated by Rac and Nck
20. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells
21. P38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy
22. Calcineurin preferentially synergizes with PKC-q to activate JNK and IL-2 promoter in T lymphocytes
23. Angiotensin II stimulates calcium-dependent activation of c-Jun N-terminal kinase